QY Research > レポート一覧 > 食品及び飲料 > 支原体検査世界市場の発展状況と動向 2024-2030

支原体検査世界市場の発展状況と動向 2024-2030

英文タイトル: Global Mycoplasma Testing Market Insights, Forecast to 2030

支原体検査世界市場の発展状況と動向 2024-2030
  • レポートID:272865
  • 発表時期:2024-04-25
  • 訪問回数:855
  • ページ数:113
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:133
  • レポートカテゴリ: 食品及び飲料

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

サンプルお申込み

shenQingYangBen

お問い合わせ

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は支原体検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは支原体検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の支原体検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは支原体検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に支原体検査市場を分類しています。本研究に含まれる主な企業は:Charles River Laboratories International、Merck Kgaa、Lonza Group、Roche Diagnostics、SGS、Thermo Fisher Scientific、American Type Culture Collection、Biounique Testing Laboratories、Invivogen、Promocell、Biological Industries Israel Beit Haemek、Wuxi Apptec、Norgen Biotek

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
PCR
ELSA
Enzymatic Methods
DNA Staining

用途別の市場セグメント:
Pharmaceuticals
Food And Beverage Testing
Biotechnology, Biomedical Drugs
Environmental Test
Academic Research Institute
Other

レポートの詳細内容
世界の支原体検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、支原体検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の支原体検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の支原体検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、支原体検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

支原体検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:支原体検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:支原体検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3支原体検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:支原体検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:支原体検査の主要企業の概要を提供し、製品の説明と仕様、支原体検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.

Market Analysis and Insights: Global Mycoplasma Testing Market
The global Mycoplasma Testing market is projected to grow from US$ 554.8 million in 2024 to US$ 1054.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast period.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.

Report Covers:
This report presents an overview of global market for Mycoplasma Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Mycoplasma Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Mycoplasma Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mycoplasma Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Mycoplasma Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Mycoplasma Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River Laboratories International, Merck Kgaa, Lonza Group, Roche Diagnostics, SGS, Thermo Fisher Scientific, American Type Culture Collection, Biounique Testing Laboratories and Invivogen, etc.

Market Segmentation
By Company
    Charles River Laboratories International
    Merck Kgaa
    Lonza Group
    Roche Diagnostics
    SGS
    Thermo Fisher Scientific
    American Type Culture Collection
    Biounique Testing Laboratories
    Invivogen
    Promocell
    Biological Industries Israel Beit Haemek
    Wuxi Apptec
    Norgen Biotek

Segment by Type
    PCR
    ELSA
    Enzymatic Methods
    DNA Staining

Segment by Application
    Pharmaceuticals
    Food And Beverage Testing
    Biotechnology, Biomedical Drugs
    Environmental Test
    Academic Research Institute
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Mycoplasma Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mycoplasma Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycoplasma Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycoplasma Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 ELSA
1.2.4 Enzymatic Methods
1.2.5 DNA Staining
1.3 Market by Application
1.3.1 Global Mycoplasma Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceuticals
1.3.3 Food And Beverage Testing
1.3.4 Biotechnology, Biomedical Drugs
1.3.5 Environmental Test
1.3.6 Academic Research Institute
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Mycoplasma Testing Market Perspective (2019-2030)
2.2 Global Mycoplasma Testing Growth Trends by Region
2.2.1 Mycoplasma Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Mycoplasma Testing Historic Market Size by Region (2019-2024)
2.2.3 Mycoplasma Testing Forecasted Market Size by Region (2025-2030)
2.3 Mycoplasma Testing Market Dynamics
2.3.1 Mycoplasma Testing Industry Trends
2.3.2 Mycoplasma Testing Market Drivers
2.3.3 Mycoplasma Testing Market Challenges
2.3.4 Mycoplasma Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Mycoplasma Testing by Players
3.1.1 Global Mycoplasma Testing Revenue by Players (2019-2024)
3.1.2 Global Mycoplasma Testing Revenue Market Share by Players (2019-2024)
3.2 Global Mycoplasma Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mycoplasma Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Mycoplasma Testing Market Concentration Ratio
3.4.1 Global Mycoplasma Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Testing Revenue in 2023
3.5 Global Key Players of Mycoplasma Testing Head office and Area Served
3.6 Global Key Players of Mycoplasma Testing, Product and Application
3.7 Global Key Players of Mycoplasma Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Mycoplasma Testing Breakdown Data by Type
4.1 Global Mycoplasma Testing Historic Market Size by Type (2019-2024)
4.2 Global Mycoplasma Testing Forecasted Market Size by Type (2025-2030)

5 Mycoplasma Testing Breakdown Data by Application
5.1 Global Mycoplasma Testing Historic Market Size by Application (2019-2024)
5.2 Global Mycoplasma Testing Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Mycoplasma Testing Market Size (2019-2030)
6.2 North America Mycoplasma Testing Market Size by Type
6.2.1 North America Mycoplasma Testing Market Size by Type (2019-2024)
6.2.2 North America Mycoplasma Testing Market Size by Type (2025-2030)
6.2.3 North America Mycoplasma Testing Market Share by Type (2019-2030)
6.3 North America Mycoplasma Testing Market Size by Application
6.3.1 North America Mycoplasma Testing Market Size by Application (2019-2024)
6.3.2 North America Mycoplasma Testing Market Size by Application (2025-2030)
6.3.3 North America Mycoplasma Testing Market Share by Application (2019-2030)
6.4 North America Mycoplasma Testing Market Size by Country
6.4.1 North America Mycoplasma Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Mycoplasma Testing Market Size by Country (2019-2024)
6.4.3 North America Mycoplasma Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Mycoplasma Testing Market Size (2019-2030)
7.2 Europe Mycoplasma Testing Market Size by Type
7.2.1 Europe Mycoplasma Testing Market Size by Type (2019-2024)
7.2.2 Europe Mycoplasma Testing Market Size by Type (2025-2030)
7.2.3 Europe Mycoplasma Testing Market Share by Type (2019-2030)
7.3 Europe Mycoplasma Testing Market Size by Application
7.3.1 Europe Mycoplasma Testing Market Size by Application (2019-2024)
7.3.2 Europe Mycoplasma Testing Market Size by Application (2025-2030)
7.3.3 Europe Mycoplasma Testing Market Share by Application (2019-2030)
7.4 Europe Mycoplasma Testing Market Size by Country
7.4.1 Europe Mycoplasma Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Mycoplasma Testing Market Size by Country (2019-2024)
7.4.3 Europe Mycoplasma Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Mycoplasma Testing Market Size (2019-2030)
8.2 China Mycoplasma Testing Market Size by Type
8.2.1 China Mycoplasma Testing Market Size by Type (2019-2024)
8.2.2 China Mycoplasma Testing Market Size by Type (2025-2030)
8.2.3 China Mycoplasma Testing Market Share by Type (2019-2030)
8.3 China Mycoplasma Testing Market Size by Application
8.3.1 China Mycoplasma Testing Market Size by Application (2019-2024)
8.3.2 China Mycoplasma Testing Market Size by Application (2025-2030)
8.3.3 China Mycoplasma Testing Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Mycoplasma Testing Market Size (2019-2030)
9.2 Asia Mycoplasma Testing Market Size by Type
9.2.1 Asia Mycoplasma Testing Market Size by Type (2019-2024)
9.2.2 Asia Mycoplasma Testing Market Size by Type (2025-2030)
9.2.3 Asia Mycoplasma Testing Market Share by Type (2019-2030)
9.3 Asia Mycoplasma Testing Market Size by Application
9.3.1 Asia Mycoplasma Testing Market Size by Application (2019-2024)
9.3.2 Asia Mycoplasma Testing Market Size by Application (2025-2030)
9.3.3 Asia Mycoplasma Testing Market Share by Application (2019-2030)
9.4 Asia Mycoplasma Testing Market Size by Region
9.4.1 Asia Mycoplasma Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Mycoplasma Testing Market Size by Region (2019-2024)
9.4.3 Asia Mycoplasma Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mycoplasma Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Mycoplasma Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Mycoplasma Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Charles River Laboratories International
11.1.1 Charles River Laboratories International Company Details
11.1.2 Charles River Laboratories International Business Overview
11.1.3 Charles River Laboratories International Mycoplasma Testing Introduction
11.1.4 Charles River Laboratories International Revenue in Mycoplasma Testing Business (2019-2024)
11.1.5 Charles River Laboratories International Recent Developments
11.2 Merck Kgaa
11.2.1 Merck Kgaa Company Details
11.2.2 Merck Kgaa Business Overview
11.2.3 Merck Kgaa Mycoplasma Testing Introduction
11.2.4 Merck Kgaa Revenue in Mycoplasma Testing Business (2019-2024)
11.2.5 Merck Kgaa Recent Developments
11.3 Lonza Group
11.3.1 Lonza Group Company Details
11.3.2 Lonza Group Business Overview
11.3.3 Lonza Group Mycoplasma Testing Introduction
11.3.4 Lonza Group Revenue in Mycoplasma Testing Business (2019-2024)
11.3.5 Lonza Group Recent Developments
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Mycoplasma Testing Introduction
11.4.4 Roche Diagnostics Revenue in Mycoplasma Testing Business (2019-2024)
11.4.5 Roche Diagnostics Recent Developments
11.5 SGS
11.5.1 SGS Company Details
11.5.2 SGS Business Overview
11.5.3 SGS Mycoplasma Testing Introduction
11.5.4 SGS Revenue in Mycoplasma Testing Business (2019-2024)
11.5.5 SGS Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Mycoplasma Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Mycoplasma Testing Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 American Type Culture Collection
11.7.1 American Type Culture Collection Company Details
11.7.2 American Type Culture Collection Business Overview
11.7.3 American Type Culture Collection Mycoplasma Testing Introduction
11.7.4 American Type Culture Collection Revenue in Mycoplasma Testing Business (2019-2024)
11.7.5 American Type Culture Collection Recent Developments
11.8 Biounique Testing Laboratories
11.8.1 Biounique Testing Laboratories Company Details
11.8.2 Biounique Testing Laboratories Business Overview
11.8.3 Biounique Testing Laboratories Mycoplasma Testing Introduction
11.8.4 Biounique Testing Laboratories Revenue in Mycoplasma Testing Business (2019-2024)
11.8.5 Biounique Testing Laboratories Recent Developments
11.9 Invivogen
11.9.1 Invivogen Company Details
11.9.2 Invivogen Business Overview
11.9.3 Invivogen Mycoplasma Testing Introduction
11.9.4 Invivogen Revenue in Mycoplasma Testing Business (2019-2024)
11.9.5 Invivogen Recent Developments
11.10 Promocell
11.10.1 Promocell Company Details
11.10.2 Promocell Business Overview
11.10.3 Promocell Mycoplasma Testing Introduction
11.10.4 Promocell Revenue in Mycoplasma Testing Business (2019-2024)
11.10.5 Promocell Recent Developments
11.11 Biological Industries Israel Beit Haemek
11.11.1 Biological Industries Israel Beit Haemek Company Details
11.11.2 Biological Industries Israel Beit Haemek Business Overview
11.11.3 Biological Industries Israel Beit Haemek Mycoplasma Testing Introduction
11.11.4 Biological Industries Israel Beit Haemek Revenue in Mycoplasma Testing Business (2019-2024)
11.11.5 Biological Industries Israel Beit Haemek Recent Developments
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Details
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec Mycoplasma Testing Introduction
11.12.4 Wuxi Apptec Revenue in Mycoplasma Testing Business (2019-2024)
11.12.5 Wuxi Apptec Recent Developments
11.13 Norgen Biotek
11.13.1 Norgen Biotek Company Details
11.13.2 Norgen Biotek Business Overview
11.13.3 Norgen Biotek Mycoplasma Testing Introduction
11.13.4 Norgen Biotek Revenue in Mycoplasma Testing Business (2019-2024)
11.13.5 Norgen Biotek Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Mycoplasma Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of PCR
    Table 3. Key Players of ELSA
    Table 4. Key Players of Enzymatic Methods
    Table 5. Key Players of DNA Staining
    Table 6. Global Mycoplasma Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Mycoplasma Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Mycoplasma Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Mycoplasma Testing Market Share by Region (2019-2024)
    Table 10. Global Mycoplasma Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Mycoplasma Testing Market Share by Region (2025-2030)
    Table 12. Mycoplasma Testing Market Trends
    Table 13. Mycoplasma Testing Market Drivers
    Table 14. Mycoplasma Testing Market Challenges
    Table 15. Mycoplasma Testing Market Restraints
    Table 16. Global Mycoplasma Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Mycoplasma Testing Revenue Share by Players (2019-2024)
    Table 18. Global Top Mycoplasma Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing as of 2023)
    Table 19. Global Mycoplasma Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Mycoplasma Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Mycoplasma Testing, Headquarters and Area Served
    Table 22. Global Key Players of Mycoplasma Testing, Product and Application
    Table 23. Global Key Players of Mycoplasma Testing, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Mycoplasma Testing Revenue Market Share by Type (2019-2024)
    Table 27. Global Mycoplasma Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Mycoplasma Testing Revenue Market Share by Type (2025-2030)
    Table 29. Global Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Mycoplasma Testing Revenue Share by Application (2019-2024)
    Table 31. Global Mycoplasma Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Mycoplasma Testing Revenue Share by Application (2025-2030)
    Table 33. North America Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Mycoplasma Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Mycoplasma Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Mycoplasma Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Mycoplasma Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Mycoplasma Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Mycoplasma Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Mycoplasma Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Mycoplasma Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Mycoplasma Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Mycoplasma Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Mycoplasma Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Mycoplasma Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Mycoplasma Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Mycoplasma Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Mycoplasma Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Mycoplasma Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Mycoplasma Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Mycoplasma Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Mycoplasma Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Charles River Laboratories International Company Details
    Table 66. Charles River Laboratories International Business Overview
    Table 67. Charles River Laboratories International Mycoplasma Testing Product
    Table 68. Charles River Laboratories International Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 69. Charles River Laboratories International Recent Developments
    Table 70. Merck Kgaa Company Details
    Table 71. Merck Kgaa Business Overview
    Table 72. Merck Kgaa Mycoplasma Testing Product
    Table 73. Merck Kgaa Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 74. Merck Kgaa Recent Developments
    Table 75. Lonza Group Company Details
    Table 76. Lonza Group Business Overview
    Table 77. Lonza Group Mycoplasma Testing Product
    Table 78. Lonza Group Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 79. Lonza Group Recent Developments
    Table 80. Roche Diagnostics Company Details
    Table 81. Roche Diagnostics Business Overview
    Table 82. Roche Diagnostics Mycoplasma Testing Product
    Table 83. Roche Diagnostics Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 84. Roche Diagnostics Recent Developments
    Table 85. SGS Company Details
    Table 86. SGS Business Overview
    Table 87. SGS Mycoplasma Testing Product
    Table 88. SGS Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 89. SGS Recent Developments
    Table 90. Thermo Fisher Scientific Company Details
    Table 91. Thermo Fisher Scientific Business Overview
    Table 92. Thermo Fisher Scientific Mycoplasma Testing Product
    Table 93. Thermo Fisher Scientific Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 94. Thermo Fisher Scientific Recent Developments
    Table 95. American Type Culture Collection Company Details
    Table 96. American Type Culture Collection Business Overview
    Table 97. American Type Culture Collection Mycoplasma Testing Product
    Table 98. American Type Culture Collection Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 99. American Type Culture Collection Recent Developments
    Table 100. Biounique Testing Laboratories Company Details
    Table 101. Biounique Testing Laboratories Business Overview
    Table 102. Biounique Testing Laboratories Mycoplasma Testing Product
    Table 103. Biounique Testing Laboratories Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 104. Biounique Testing Laboratories Recent Developments
    Table 105. Invivogen Company Details
    Table 106. Invivogen Business Overview
    Table 107. Invivogen Mycoplasma Testing Product
    Table 108. Invivogen Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 109. Invivogen Recent Developments
    Table 110. Promocell Company Details
    Table 111. Promocell Business Overview
    Table 112. Promocell Mycoplasma Testing Product
    Table 113. Promocell Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 114. Promocell Recent Developments
    Table 115. Biological Industries Israel Beit Haemek Company Details
    Table 116. Biological Industries Israel Beit Haemek Business Overview
    Table 117. Biological Industries Israel Beit Haemek Mycoplasma Testing Product
    Table 118. Biological Industries Israel Beit Haemek Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 119. Biological Industries Israel Beit Haemek Recent Developments
    Table 120. Wuxi Apptec Company Details
    Table 121. Wuxi Apptec Business Overview
    Table 122. Wuxi Apptec Mycoplasma Testing Product
    Table 123. Wuxi Apptec Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 124. Wuxi Apptec Recent Developments
    Table 125. Norgen Biotek Company Details
    Table 126. Norgen Biotek Business Overview
    Table 127. Norgen Biotek Mycoplasma Testing Product
    Table 128. Norgen Biotek Revenue in Mycoplasma Testing Business (2019-2024) & (US$ Million)
    Table 129. Norgen Biotek Recent Developments
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Mycoplasma Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Mycoplasma Testing Market Share by Type: 2023 VS 2030
    Figure 3. PCR Features
    Figure 4. ELSA Features
    Figure 5. Enzymatic Methods Features
    Figure 6. DNA Staining Features
    Figure 7. Global Mycoplasma Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Mycoplasma Testing Market Share by Application: 2023 VS 2030
    Figure 9. Pharmaceuticals Case Studies
    Figure 10. Food And Beverage Testing Case Studies
    Figure 11. Biotechnology, Biomedical Drugs Case Studies
    Figure 12. Environmental Test Case Studies
    Figure 13. Academic Research Institute Case Studies
    Figure 14. Other Case Studies
    Figure 15. Mycoplasma Testing Report Years Considered
    Figure 16. Global Mycoplasma Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Mycoplasma Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Mycoplasma Testing Market Share by Region: 2023 VS 2030
    Figure 19. Global Mycoplasma Testing Market Share by Players in 2023
    Figure 20. Global Top Mycoplasma Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Mycoplasma Testing Revenue in 2023
    Figure 22. North America Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Mycoplasma Testing Market Share by Type (2019-2030)
    Figure 24. North America Mycoplasma Testing Market Share by Application (2019-2030)
    Figure 25. North America Mycoplasma Testing Market Share by Country (2019-2030)
    Figure 26. United States Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Mycoplasma Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Mycoplasma Testing Market Share by Type (2019-2030)
    Figure 30. Europe Mycoplasma Testing Market Share by Application (2019-2030)
    Figure 31. Europe Mycoplasma Testing Market Share by Country (2019-2030)
    Figure 32. Germany Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Mycoplasma Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Mycoplasma Testing Market Share by Type (2019-2030)
    Figure 40. China Mycoplasma Testing Market Share by Application (2019-2030)
    Figure 41. Asia Mycoplasma Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Mycoplasma Testing Market Share by Type (2019-2030)
    Figure 43. Asia Mycoplasma Testing Market Share by Application (2019-2030)
    Figure 44. Asia Mycoplasma Testing Market Share by Region (2019-2030)
    Figure 45. Japan Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Mycoplasma Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Mycoplasma Testing Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Mycoplasma Testing Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Mycoplasma Testing Market Share by Country (2019-2030)
    Figure 55. Brazil Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Mycoplasma Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Charles River Laboratories International Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 62. Merck Kgaa Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 63. Lonza Group Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 64. Roche Diagnostics Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 65. SGS Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 67. American Type Culture Collection Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 68. Biounique Testing Laboratories Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 69. Invivogen Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 70. Promocell Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 71. Biological Industries Israel Beit Haemek Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 72. Wuxi Apptec Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 73. Norgen Biotek Revenue Growth Rate in Mycoplasma Testing Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)